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ABSTRACT
Glial cells missing homolog 1 (GCM1) is a tran-
scription factor essential for placental development.
GCM1 promotes syncytiotrophoblast formation
and placental vasculogenesis by activating
fusogenic and proangiogenic gene expression in
placenta. GCM1 activity is regulated by multiple
post-translational modifications. The cAMP/
PKA-signaling pathway promotes CBP-mediated
GCM1 acetylation and stabilizes GCM1, whereas
hypoxia-induced GSK-3b-mediated phosphorylation
of Ser322 causes GCM1 ubiquitination and degrad-
ation. How and whether complex modifications of
GCM1 are coordinated is not known. Here we show
that the interaction of GCM1 and dual-specificity
phosphatase 23 (DUSP23) is enhanced by PKA-
dependent phosphorylation of GCM1 on Ser269 and
Ser275. The recruitment of DUSP23 reverses
GSK-3b-mediated Ser322 phosphorylation, which in
turn promotes GCM1 acetylation, stabilization and
activation. Supporting a central role in coordinating
GCM1 modifications, knockdown of DUSP23 sup-
pressed GCM1 target gene expression and placental
cell fusion. Our study identifies DUSP23 as a novel
factor that promotes placental cell fusion and
reveals a complex regulation of GCM1 activity by
coordinated phosphorylation, dephosphorylation
and acetylation.
INTRODUCTION
Glial cells missing homolog 1 (GCM1, also known
as GCMa) is a key transcription factor in placental
development. Genetic ablation of mouse GCM1 results
in embryonic lethality due to failure of labyrinth layer
formation and fusion of trophoblasts to syncytiotro-
phoblasts (1,2). Correlatively, mouse GCM1 has been
shown to regulate expression of integrin-a4 and Rb1
genes, which play important roles in the development of
syncytiotrophoblast and labyrinth (3). Although GCM1 is
primarily expressed in placenta, its expression has also
been reported in mouse kidney and thymus (4). The
physiological functions of GCM1 in kidney and thymus
are not known. Interestingly, in utero injection of
GCM1-expressing retrovirus into mouse embryonic
brains indicates that GCM1 promotes the generation of
a minor population of glial cells (5).
Human GCM1 positively regulates syncytin-1 and
placental growth factor (PGF) gene expression, which is
critical for trophoblastic fusion and placental
vasculogenesis (6–9). Clinically, expression of GCM1 as
well as its target genes, syncytin-1 and PGF, is decreased
in preeclampsia, which is a prevalent pregnancy disorder,
and in hypoxic placental cells (10–12). Since hypoxia
caused by incomplete trophoblast invasion and impaired
spiral arterial remodeling is associated with preeclampsia
(13,14), we have recently investigated the molecular
mechanism by which hypoxia decreases GCM1 expres-
sion. We demonstrated that GSK-3b mediates phosphor-
ylation of GCM1 on Ser322, which is recognized by the
F-box protein, FBW2, to promote GCM1 ubiquitination
and degradation (15,16). In addition, GSK-3b is activated
to further decrease GCM1 stability in placental cells
subject to hypoxia. Therefore, enhanced phosphorylation
of Ser322 by GSK-3b suppresses GCM1 activity in
placenta, which may contribute to the development of
preeclampsia.
Our previous studies have demonstrated that GCM1
activity can be regulated by ubiquitination, acetylation
and sumoylation (16–18). Indeed, FBW2, CBP and
Ubc9 interact with GCM1 to promote ubiquitination,
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Although these modiﬁcations all affect GCM1 stability
and transcriptional activity, whether they are mechanis-
tically connected is not known. Here we identify dual-
speciﬁcity phosphatase 23 (DUSP23), which belongs to
the type-I cysteine-based protein tyrosine phosphatase
(PTP) superfamily (19), as a new GCM1-associated
protein that mediates Ser322 dephosphorylation and
thereby prolongs the half-life of GCM1. We further
demonstrate that DUSP23-mediated GCM1 dephospho-
rylation is a prerequisite step for further GCM1 acetyl-
ation by CBP, which positively regulates GCM1.
In addition, knockdown of DUSP23 suppresses GCM1
target gene expression and placental cell fusion,
supporting a critical role of DUSP23 in regulation of
GCM1 modiﬁcation and function. Collectively, our
study delineates the mechanism underlying GCM1
dephosphorylation and suggests a cascade of coordinated
phosphorylation, dephosphorylation and acetylation
events that is critical for controlling GCM1 activity in
the regulation of placental cell fusion.
MATERIALS AND METHODS
Plasmid constructs
The pGal4-FLAG empty expression plasmid and the
pGal4-GCM1-FLAG expression plasmids harboring
full-length or truncated GCM1 have been described
previously (17). Human GCM1 cDNA fragment with an
N-terminal triple HA tag or a C-terminal triple FLAG tag
was subcloned into a pEF1 expression vector under
control of EF1 promoter to generate the pHA-GCM1
or pGCM1-FLAG expression plasmid. The pHA-
GCM1SSAA expression plasmid was similar to
pHA-GCM1 except that the GCM1 cDNA harbored
Ser269-to-Ala and Ser275-to-Ala mutations. The pHA-
GCM1SSEE expression plasmid harbored Ser269-to-Glu
and Ser275-to-Glu mutations in the GCM1 cDNA. The
pDUSP23-Myc or pDUSP23-FLAG expression plasmid
was constructed by subcloning human DUSP23 cDNA
fragment with a C-terminal quadruple Myc tag or triple
FLAG tag into the pEF1 expression vector. The
pDUSP23DACS-Myc expression plasmid was similar to
pDUSP23-Myc except that the DUSP23 cDNA harbored
Asp65-to-Ala and Cys95-to-Ser mutations in the active
site of DUSP23. The reporter plasmid, p(GBS)4E1BLuc,
which contains four copies of GCM1-binding site, has
been described previously (17).
Cell culture, transfection and lentivirus transduction
293T and BeWo cells were obtained from the American
Type Culture Collection (Manassas, VA). BeWo31 cells
which stably expressing HA-tagged GCM1 were estab-
lished as previously described (16). 293T cells were main-
tained at 37 C in minimal essential medium alpha
medium, with 10% fetal bovine serum (FBS), 100mg/ml
streptomycin and 100U/ml penicillin. BeWo and BeWo31
were maintained at 37 C in F-12K medium supplemented
with 15% FBS and the aforementioned antibiotics.
Because the expression of HA-tagged GCM1 in BeWo31
cells is under control of CMV promoter whose activity is
not affected by hypoxia (15), BeWo31 cells provided a
useful system to investigate hypoxia-induced GCM1
phosphorylation and degradation in this study. Villous
cytotrophoblast (CTB) cells from term placentas were
prepared and cultured as previously described (15). For
transient expression, 293T cells were transfected with
expression plasmid(s) using the calcium phosphate
coprecipitation method or the Lipofectamine 2000
reagent (Invitrogen, Carlsbad, CA). Luciferase assays
were performed as previously described (20). Speciﬁc
luciferase activities were normalized by protein concentra-
tion. Protein concentrations were measured by using the
BCA protein assay kit (Pierce, Rockford, IL). Hypoxia
was achieved by exposing cells to 1% O2,5 %C O 2 and
94% N2 in a multigas incubator (Astec, Fukuoka, Japan),
whereas normoxia was achieved with 20% O2,5 %C O 2
and balanced N2.
Recombinant lentivirus strain expressing DUSP23-Myc
or DUSP23DACS-Myc was prepared using a modiﬁed
pCDH expression vector (SBI, Mountain View, CA)
harboring a puromycin selection cassette. BeWo31
or 293T cells were infected with the lentivirus strains har-
boring empty vector, DUSP23-Myc and DUSP23DACS-
Myc, respectively, followed by antibiotic selection using
100mg/ml puromycin. Puromycin-resistant clones were
pooled for GCM1 stability, phosphorylation and acetyl-
ation studies in this study. For RNA interference, a
pLKO.1-Puro lentiviral construct harboring a scramble
(Addgene plasmid 1864) or DUSP23 shRNA (50-GCTGA
AATCCGACGACTACGA-30, National RNAi Core
Facility of Taiwan) was packed into recombinant lentivirus
strainforestablishingstable293T,BeWoandBeWo31cells
expressing scramble or DUSP23 shRNA.
Immunoprecipitation and immunoblotting
For GCM1andDUSP23 interaction study, 293Tcells were
transfected with pHA-GCM1 and pDUSP23-FLAG for
48h.Cellswerethenharvestedinthelysisbuffercontaining
50mM Tris–HCl (pH 7.5), 150mM NaCl, 2mM EDTA,
10%glycerol,0.5%NP-40,5mMNaF,1mMNa3VO4and
a protease inhibitor cocktail (Sigma, St. Louis, MO) for
immunoprecipitation and immunoblotting with anti-HA
or anti-FLAG mAb (Sigma). Interaction between GCM1
and DUSP23 in BeWo cells was analyzed in similar
conditions using GCM1 and DUSP23 antibodies. Human
DUSP23 antibody was raised in guinea pigs using a
His-tagged DUSP23 antigen prepared in the pET21-
BL21(DE3) expression system (Novagen, Madison, WI).
To study the effect of DUSP23 on GCM1 ubiquitination,
293T cells were transfected with pGCM1-FLAG, pHA-Ub
and pUDSP23-Myc or pDUSP23DACS-Myc, followed by
treatment with MG132. Analysis of the ubiquitinated
GCM1 was performed by immunoprecipitation with
FLAG mAb and immunoblotting with HA mAb as
previously described (16).
Mapping the DUSP23-interacting domain in GCM1
To map the GCM1 domain that interacts with DUSP23,
pull-down assays were performed. In brief, 293T cells were
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indicated deletion mutant pGal4-GCM1-FLAG plasmid.
At 48h post-transfection, cells were harvested in the lysis
buffer (20mM Tris–HCl, pH 8.0, 150mM NaCl, 1mM
EDTA, 5% glycerol, 0.5% NP-40, 5mM NaF, 1mM
Na3VO4 and a protease inhibitor cocktail). The cell
lysate was incubated with MBP or MBP-DUSP23
pre-bound to maltose-conjugated agarose matrix in the
lysis buffer at 4 C for 4h before washing three times
with the lysis buffer. The proteins pulled down were
analyzed by immunoblotting with FLAG mAb.
Recombinant MBP fusion protein, MBP-DUSP23, was
prepared using the pMAL-c2 expression system (NEB,
Beverly, MA).
GCM1 stability analysis
To study the effect of DUSP23 on GCM1 stability, 293T
cells were transfected with pGCM1-FLAG and increasing
amounts of pDUSP23-Myc or pDUSP23DACS-Myc for
48h. Cells were than harvested for immunoblotting using
FLAG mAb. To study the effect of DUSP23 on GCM1
half-life, mock BeWo31 cells and BeWo31 cells expressing
DUSP23-Myc- or DUSP23DACS-Myc were treated with
cycloheximide for the indicated period of time and then
harvested for immunoblotting with HA mAb. In a
separate experiment, the three groups of BeWo31 cells
were incubated under normoxic and hypoxic conditions
for 24h and then harvested for immunoblotting analysis
of the HA-GCM1 protein level. Likewise, the three groups
of BeWo31 cells incubated under normoxic and hypoxic
conditions were subjected to immunoprecipitation with a
phospho-speciﬁc antibody to Ser322 and immunoblotting
with HA mAb to study the effect of DUSP23 on Ser322
dephosphorylation in GCM1. Preparation of the
phospho-speciﬁc antibody to Ser322, p-Ser322-GCM1,
has been previously described (15). Band intensities were
analyzed using a Kodak DC290 zoom digital camera and
1D image analysis software.
In vitro GSK-3b phosphorylation and DUSP23
dephosphorylation of GCM1
Recombinant MBP fusion protein, MBP-GCM1
(167–349), which contained the amino acids 167–349 of
GCM1, was prepared using the pMAL-c2 expression
vector. As a control, the mutant MBP-GCM1
(167–349)AA, which harbored Ser322-to-Ala and
Ser326-to-Ala mutations on the GSK-3b phosphorylation
site in GCM1, was prepared. An amount of 1mgo f
puriﬁed MBP, wild-type or mutant MBP-GCM1
(167–349) was incubated with 1U recombinant GSK-3b
(Sigma), 1mCi g-[
32P]-ATP and 0.2mM ATP in the
reaction buffer (25mM MOPS, pH 7.2, 12.5mM
b-glycerophosphate, 25mM MgCl2, 5mM EGTA, 2mM
EDTA, 25mM DTT) at 30 C for 1h. Recombinant
DUSP23 and DUSP23DACS proteins with a C-terminal
His tag, DUSP23-His and DUSP23DACS-His, were
prepared using the pET21 expression vector. Similarly,
recombinant DUSP23 with a C-terminal FLAG
tag, DUSP23-FLAG, was prepared using the pET21
expression vector. The phosphatase activities of
recombinant DUSP23 and DUSP23DACS proteins were
conﬁrmed by in vitro phosphatase assay using
p-nitrophenyl phosphate (PNPP) as a substrate (data
not shown). Dephosphorylation of GCM1 by DUSP23
was analyzed by incubation of the above-mentioned
GSK-3b-treated wild-type or mutant MBP-GCM1
(167–349) with increasing amounts of recombinant
DUSP23-His and DUSP23DACS-His, followed by
SDS–PAGE electrophoresis and autoradiography.
Regulation of GCM1–DUSP23 interaction
To study regulation of GCM1–DUSP23 interaction by
cAMP/PKA-signaling, BeWo cells were treated with or
without 50mM forskolin for 24h and subjected to
coimmunoprecipitation with GCM1 and DUSP23
antibodies. Phosphorylation of Ser269 and Ser275 in
GCM1 by PKA was analyzed by immunoblotting with
the p-Ser269275-GCM1 antibody, which was raised
against a chemically synthesized phosphopeptide,
YEKRKLS(PO3)SSRTYS(PO3)SGDL, in guinea pigs.
For in vitro study of regulation of GCM1–DUSP23 inter-
action by PKA, 0.5mg of MBP or MBP-GCM1(167–349)
protein pre-bound to maltose-conjugated agarose matrix
was incubated with 0.5U PKA (Sigma) and 1mM ATP in
the reaction buffer (20mM Tris–HCl, pH 7.5, 100mM
NaCl, 12mM MgCl2)a t3 0  C for 30min. After washing,
the matrix was incubated with 0.1mg of DUSP23-FLAG
for pull-down assays.
Cell fusion analysis
Cell-cell fusion was analyzed based on a previously
described co-culture assay system (6). Brieﬂy, 293T cells
were transfected with the red ﬂuorescent protein plasmid,
pDsRed1-N1 (Clontech, Mountain View, CA), for 24h.
To study the role of DUSP23 in placental cell fusion, the
transfected 293T cells were trypsinized and co-cultured
with BeWo cells expressing scramble or DUSP23
shRNA in six-well culture dishes, followed by treatment
with or without 50mM forskolin. After another 24h at
37 C, cell fusions were examined under an Olympus
microscope (Tokyo, Japan) equipped with a cooled
charge-coupled device camera (DP50). Three microscopic
ﬁelds per sample were randomly selected for examination
in each of three independent experiments. Images were
prepared for presentation using Adobe Photoshop 6.0.
Quantiﬁcation of cell fusion was calculated as a fusion
index of (N-S)/T, where N is the number of nuclei in the
syncytia, S is the number of syncytia and T is the total
number of nuclei counted.
Quantitative real-time PCR
RNA was isolated using RNeasy reagents (Qiagen,
Hilden, Germany) and then transcribed into cDNA
using SuperScript III reagents (Invitrogen) with an
oligo-(dT)20 primer. Quantiﬁcation of the transcript
levels of GCM1 target genes was preformed in the
LightCycler system (Roche, Basel, Switzerland) using a
commercial SYBR Green reaction reagent (Qiagen) and
speciﬁc primer sets. The sequences of primer sets were 50-T
GGAACAACTTCAGCACAGA-30 and 50-GCCATTCA
850 Nucleic Acids Research, 2011,Vol. 39,No. 3AACAACGATAGG-30 for syncytin-1, 50-CGACTCAGT
GTAAACAGCCA-30 and 50-CCACAGAAGCAAGACA
AAGAAAAT-30 for syncytin-2, 50-GCAGAGGCCGGC
ATTC-30 and 50-TCAGAGGTGGAAGTGGTACCCT-30
for PGF, 50-CTCCTGGCCATCATGCTCTC-30 and 50-G
GCCACCAAGATGAGAAA-30 for MFSD2, 50-AACTC
CATCATGAAGTGTGACG-30 and 50-GATCCACATC
TGCTGGAAGG-30 for b-actin and 50-GCCATCAATG
ACCCCTTCATT-30 and 50-TTGACGGTGCCATGGA
ATTT-30 for GAPDH.
RESULTS
Characterization of GCM1–DUSP23 interaction
To further understand the regulation of GCM1 activity,
we identiﬁed DUSP23 as a GCM1-associated protein
using a tandem afﬁnity puriﬁcation approach coupled
with mass spectrometry (Supplementary Figure S1). We
then investigated whether DUSP23 physically interacts
with GCM1. To this end, 293T cells were transfected
with pHA-GCM1 and pDUSP23-FLAG, followed by
immunoprecipitation and immunoblotting with HA and
FLAG monoclonal antibodies (mAbs). As shown in the
left panel of Figure 1A, a speciﬁc interaction between
HA-GCM1 and DUSP23-FLAG was detected. We
further demonstrated that GCM1 interacts with
DUSP23, but not DUSP22, which is a closely related
DUSP (Supplementary Figure S2). The speciﬁc inter-
action between endogenous GCM1 and DUSP23 was
conﬁrmed in placental BeWo cells using DUSP23 and
GCM1 antibodies for immunoprecipitation and immuno-
blotting, respectively (Figure 1A, middle). A direct inter-
action between GCM1 and DUSP23 was veriﬁed by the
pull-down of recombinant DUSP23-FLAG proteins with
MBP-GCM1, but not MBP (Figure 1A, right).
We next mapped the interaction domain of GCM1 for
DUSP23. Recombinant MBP or MBP-DUSP23 proteins
were incubated with cell lysates prepared from 293T cells
transfected with pGal4-GCM1-FLAG expression
plasmids encoding the Gal4 DNA-binding domain fused
with either full-length or different truncated GCM1
Figure 1. Characterization of the interaction between DUSP23 and GCM1. (A) Analysis of DUSP23-GCM1 interaction by coimmunoprecipitation.
293T cells were transfected with 1mg of pHA-GCM1 and 1mg of pDUSP23-FLAG for 48h and then harvested for immunoprecipitation (IP) and
immunoblotting (IB) with FLAG and HA mAbs. BeWo cells were subjected to immunoprecipitation with normal IgG or DUSP23 antibody,
followed by immunoblotting with GCM1 antibody. Maltose-conjugated agarose matrix pre-loaded with 0.5mg of recombinant MBP or
MBP-GCM1 protein was incubated with 0.1mg of recombinant DUSP23-FLAG for pull-down analysis and immunoblotting with FLAG mAb.
(B) Identiﬁcation of the DUSP23-interacting domain in GCM1. 293T cells were transfected with 1mg of pGal4-FLAG, wild-type or deletion mutant
pGal4-GCM1-FLAG expression plasmid. At 48h post-transfection, cell extracts were prepared and incubated with maltose-conjugated agarose
matrix pre-loaded with 2mg of recombinant MBP or MBP-DUSP23 protein for pull-down analysis and immunoblotting with FLAG mAb. The
middle panel is immunoblotting of Gal4-FLAG and Gal4-GCM1-FLAG proteins in the input cell extracts. The lower panel shows Coomassie
brilliant blue staining of MBP and MBP fusion proteins in pull-down assays.
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MBP, pulled down the full-length GCM1 and the GCM1
domain of amino acids 167–349. Of note, the immuno-
blotting analysis of input indicated that Gal4-
GCM1-FLAG(1–436) proteins are prone to partial deg-
radation. As a result, the intact and partially-degraded
Gal4-GCM1-FLAG(1–436) proteins were coimmunopre-
cipitated with DUSP23. Overall, the DUSP23-interacting
domain in GCM1 is localized to the region of amino acids
167–349, which also harbors the Ser322 phosphorylation
site critical for GCM1 stability (15).
Stabilization of GCM1 by DUSP23
Because GCM1 stability can be regulated by phosphoryl-
ation,wetestedtheroleofDUSP23 inregulationofGCM1
stability. To this end, 293T cells were cotransfected with
pGCM1-FLAG, a GCM1 expression plasmid and
pDUSP23-Myc or pDUSP23DACS-Myc, a wild-type or
enzyme-dead DUSP23 expression plasmid. As shown in
Figure 2A, the steady-state level of GCM1-FLAG
increased in the presence of increasing amounts of
wild-type DUSP23-Myc, but not the enzyme-dead
DUSP23DACS-Myc. We also tested the effect of
DUSP23 on GCM1-mediated transcriptional activation
by transient expression experiments. The reporter
plasmid, p(GBS)4E1BLuc, which contains four copies of
the GCM1-binding site, was cotransfected with pGCM1-
FLAG and pDUSP23-Myc or pDUSP23DACS-Myc into
293T cells. GCM1-mediated transcriptional activation was
signiﬁcantly enhanced in the presence of the wild-type
DUSP23-Myc in a dose-dependent manner (Figure 2B).
Interestingly, the enzyme-dead DUSP23DACS-Myc was
Figure 2. Regulation of GCM1 stability by DUSP23. (A) The steady state level of GCM1 increased in the presence of DUSP23. 293T cells were
transfected with 1mg of pGCM1-FLAG and the indicated amount of pDUSP23-Myc or pDUSP23DACS-Myc for 48h. Cells were harvested for
immunoblotted with FLAG, Myc or b-actin mAb. The result of a short exposure time (1min) for the level of GCM1-FLAG in 293T coexpressing
DUSP23-Myc is presented in the top of the left panel. Note that the result of a longer exposure time (5min) for the level of GCM1-FLAG in 293T
cell coexpressing DUSP23DACS-Myc is presented in the top of the right panel. For comparison, the result of a short exposure time (1min) is
provided underneath. (B) GCM1-mediated transcriptional activation is enhanced by DUSP23. 293T cells were transfected with 0.1mgo f
p(GBS)4E1BLuc and different combinations of 0.05mg of pGCM1-FLAG and increasing amounts of pDUSP23-Myc or pDUSP23DACS-Myc
for 48h. Cells were then harvested for luciferase reporter assay. Mean values and the SD obtained from three independent experiments are presented.
(C) The transcript levels of GCM1-FLAG in 293T cells coexpressing with different amounts of DUSP23-Myc were analyzed by quantitative real-time
PCR. Mean values and the SD obtained from three independent experiments are presented.
852 Nucleic Acids Research, 2011,Vol. 39,No. 3able to counteract GCM1-mediated transcriptional activa-
tion (Figure 2B), suggesting that DUSP23DACS-Myc
imposes a dominant-negative effect on GCM1 activity.
To rule out the possibility that DUSP23 upregulates
GCM1 transcription, we also measured the transcript
level of GCM1-FLAG in transfected cells by quantitative
real-time PCR. As shown in Figure 2C, the transcript level
of GCM1-FLAG was normalized against b-actin or
GAPDH and was comparable in cells expressing
GCM1-FLAG with or without increasing amounts of
DUSP23-Myc. These results suggested that the effect of
DUSP23-Myc on elevation of GCM1-FLAG protein
level is not due to differential expression of GCM1-
FLAG transcript. Taken together, these results suggested
that the phosphatase activity of DUSP23 is required
to promote GCM1 stability in order to enhance the
transcriptional activity of GCM1.
DUSP23 prevents GCM1 from ubiquitination and
prolongs the half-life of GCM1
Because GCM1 is a labile protein subject to ubiquitination
and proteasome-mediated degradation, we tested whether
DUSP23 affects GCM1 ubiquitination. To this end,
293T cells were transfected with different combinations
of pGCM1-FLAG, pHA-Ub, pDUSP23-Myc and
pDUSP23DACS-Myc expression plasmids, followed by
treatment with the proteasome inhibitor, MG132, to
enrich the ubiquitinated GCM1-FLAG. As shown in
Figure 3A, GCM1-FLAG was poly-ubiquitinated in
the presence of HA-Ub. Interestingly, the level of
poly-ubiquitinated GCM1-FLAG was signiﬁcantly lower
when DUSP23-Myc, but not DUSP23DACS-Myc,
was coexpressed (Figure 3A). We further studied
the effect of DUSP23 on the half-life of GCM1
in BeWo31 cells, which stably express HA-GCM1.
BeWo31 cells were infected with lentivirus strains
harboring empty, DUSP23-Myc, or DUSP23DACS-Myc
expression cassettes. After antibiotic selection, stable
clones were pooled and subjected to cycloheximide
chase experiments. The half-life of HA-GCM1 in mock-
infected BeWo31 cells was  120min, and was signiﬁ-
cantly prolonged in cells expressing DUSP23-Myc
after chasing for 6h (Figure 3B). Notably, the half-life of
HA-GCM1 was shorter in BeWo31 cells expressing
DUSP23DACS-Myc than in the mocked-infected BeWo
cells (Figure 3B). These results suggest that DUSP23
increases GCM1 stability by preventing GCM1
ubiquitination.
Figure 3. Regulation of GCM1 ubiquitination and half-life by DUSP23. (A) DUSP23 prevents GCM1 from ubiquitination. 293T cells were trans-
fected with different combinations of 1mg of pGCM1-FLAG, pHA-Ub, pDUSP23-Myc and pDUSP23DACS-Myc. At 24h post-transfection, cells
were treated with 40mM MG132 for an additional 10h, and then subjected to ubiquitination analysis by immunoprecipitation with FLAG mAb and
immunoblotting with HA mAb. (B) DUSP23 prolongs the half-life of GCM1. Mock BeWo31 cells or BeWo31 cells stably expressing DUSP23-Myc
or DUSP23DACS-Myc were treated with 75mM cycloheximide (CHX) for the indicated period of time. The protein levels of HA-GCM1,
DUSP23-Myc, DUSP23DACS-Myc and b-actin were then analyzed by immunoblotting with HA, Myc and b-actin mAbs. The band intensity of
HA-GCM1 and b-actin was quantiﬁed by densitometric analysis. After normalization of HA-GCM1 with b-actin, the relative levels of HA-GCM1
proteins from two independent experiments were plotted against the time course of CHX treatment.
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Because Ser322 phosphorylation controls GCM1 ubiqui-
tination and degradation, we tested whether DUSP23
stabilizes GCM1 via dephosphorylation of Ser322.
Recombinant MBP-GCM1(167–349) was subjected to
in vitro phosphorylation by GSK-3b and [
32P]-ATP.
Speciﬁc phosphorylation of Ser322 in MBP-GCM1
(167–349) by GSK-3b was observed because the mutant
MBP-GCM1(167–349)AA harboring a Ser-to-Ala
mutation in Ser322 was not phosphorylated (Figure 4A).
Labeled MBP-GCM1(167–349) was incubated with
increasing amounts of recombinant DUSP23 or
DUSP23DACS. As shown in Figure 4A, the level of
Ser322-phosphorylated MBP-GCM1(167–349) was lower
in the presence of DUSP23, but not DUSP23DACS. In
addition, the effect of DUSP23 on Ser322-phosphorylated
MBP-GCM1(167–349) was abolished by sodium
orthovanadate (Na3VO4), a speciﬁc inhibitor of PTPs
(Figure 4A). Therefore, DUSP23 was able to
dephosphorylate Ser322 in vitro.
We next tested whether DUSP23 is involved in Ser322
dephosphorylation in placental BeWo31 cells stably
expressing HA-GCM1. The mock, DUSP23-Myc-
expressing and DUSP23DACS-Myc-expressing BeWo31
cells were subjected to normoxic or hypoxic conditions
for 24h. In accordance with our previous study that
showed that hypoxia induces GCM1 degradation (15),
the protein level of HA-GCM1 in mock-infected BeWo31
cells under hypoxia was decreased to 57.5% of that in cells
under normoxia (Figure 4B, left). In contrast, HA-GCM1
was stabilized in cells expressing DUSP23-Myc under
hypoxia (90.5% of normoxic cells, Figure 4B, middle).
Interestingly, the protein level of HA-GCM1 was further
decreased to 42.3% in cells expressing DUSP23DACS-
Myc under hypoxia (Figure 4B, right). We then studied
whether the observed stabilization effect of DUSP23 was
correlated with dephosphorylation of Ser322 in GCM1. In
a separate experiment, the BeWo31 cells were subjected to
immunoprecipitation with a phospho-Ser322-speciﬁc
antibody and then immunoblotting with HA mAb. As
shown in the left panel of Figure 4C, consistent with our
previous study (15), the level of Ser322-phosphorylated
HA-GCM1 was much higher in mock-infected BeWo31
cells under hypoxia (438% relative to normoxia).
Interestingly, Ser322-phosphorylated HA-GCM1 in the
DUSP23-Myc-expressing BeWo31 cells under hypoxia
could barely be detected and was similar to that in cells
under normoxia (Figure 4C, middle). In contrast, the
level of Ser322-phosphorylated HA-GCM1 was dramatic-
ally increased in the DUSP23DACS-Myc-expressing
Figure 4. DUSP23 mediates Ser322 dephosphorylation in GCM1 in vitro and in vivo.( A) In vitro dephosphorylation of Ser322 by DUSP23.
Recombinant MBP (arrowhead), MBP-GCM1(167–349) and MBP-GCM1(167–349)AA (arrow), bound on maltose matrix were incubated with
recombinant GSK-3b proteins and [
32P]-ATP for in vitro kinase reactions at 30 C for 1h. After washing, the reaction mixtures were incubated
with increasing amounts of recombinant DUSP23-His or DUSP23DACS-His proteins in the presence or absence of 2mM sodium orthovanadate
(Na3VO4)a t3 7  C for 1h before SDS–PAGE and autoradiography. (B) DUSP23 counteracts hypoxia-induced GCM1 degradation. Mock BeWo31
cells or BeWo31 cells stably expressing DUSP23-Myc or DUSP23DACS-Myc were incubated under normoxic and hypoxic conditions for 24h and
then subjected to immunoblotting with HA, Myc and b-actin mAbs. The numbers underneath indicate the ratios of the HA-GCM1 band intensity
(normalized against b-actin) under hypoxia to that under normoxia. (C) DUSP23 suppresses hypoxia-induced Ser322 phosphorylation in placental
cells. BeWo31 cells as described in (B) were cultured under normoxia or hypoxia in the presence of MG132 for 24h, followed by
immunoprecipitation with p-Ser322-GCM1 antibody and immunoblotting with HA mAb. The numbers underneath indicate the ratios of the
Ser322-phosphorylated HA-GCM1 band intensity (normalized against HA-GCM1) under hypoxia to that under normoxia.
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Figure 4C, right). Therefore, the enzyme-dead
DUSP23DACS is able to block DUSP23-mediated
Ser322 dephosphorylation, which may underscore the
observed shortening of GCM1 half-life by
DUSP23DACS (Figure 3B). Taken together, these results
suggested that DUSP23 mediates Ser322 dephosphory-
lation in GCM1 in placental cells.
Regulation of GCM1–DUSP23 interaction by cAMP/
PKA signaling
Placental cell fusion is stimulated by activation of the
cAMP/PKA-signaling pathway, which involves stabiliza-
tion of GCM1 and activation of syncytin-1 gene expres-
sion (6,17,21,22). Together with the ﬁnding that GCM1 is
stabilized by DUSP23, we next tested the effect of cAMP/
PKA on the interaction between GCM1 and DUSP23. As
shown in Figure 5A, the interaction between GCM1 and
DUSP23 in BeWo cells was signiﬁcantly enhanced by
forskolin, which is a cAMP stimulant. Of note, the tran-
script and protein levels of DUSP23 in BeWo cells were
not affected by forskolin (Figure 5A).
Our previous study indicated that Ser269 and Ser275 are
both PKA phosphorylation sites (17). Correspondingly,
phosphorylation of both sites was detected here
after forskolin treatment using an antibody against
the phosphorylated Ser269 and Ser275 in GCM1
(Figure5A).SincebothsitesareintheDUSP23-interacting
domain of GCM1, we tested whether phosphorylation of
Ser269 and Ser275 by PKA enhances the interaction
between GCM1 and DUSP23. To this end, recombinant
MBP-GCM1(167–349)wassubjectedtoinvitroPKAphos-
phorylation for phosphorylation of Ser269 and Ser275
(Figure 5B, middle). When non-phosphorylated and
phosphorylated MBP-GCM1(167–349) were incubated
with recombinant DUSP23-FLAG in pull-down assays, a
signiﬁcant increase of interaction between phosphorylated
MBP-GCM1(167–349) and DUSP23-FLAG was detected
(Figure 5B). Subsequently, we tested whether Ser269 and
Ser275 phosphorylation correlates with increased inter-
action between GCM1 and DUSP23 in placental cells.
BeWo and primary cytotrophoblast (CTB) cells were
treated with or without forskolin, followed by immunopre-
cipitation and immunoblotting analysis. As shown
in Figure 5C, forskolin stimulated Ser269 and Ser275
phosphorylation in both cell types. In addition, the PKA
inhibitor H89 abolished the forskolin-induced GCM1
phosphorylation, supporting the position that PKA
mediates Ser269 and Ser275 phosphorylation in placental
cells. Correspondingly, the interaction between GCM1 and
DUSP23 was enhanced in the presence of forskolin in both
cell types, and the enhancement effect of forskolin was
impaired by H89 (Figure 5C).
We further conﬁrmed that Ser269 and Ser275 are
critical for PKA in promoting GCM1–DUSP23 inter-
action by site-directed mutagenesis. 293T cells were trans-
fected with different combinations of pDUSP23-FLAG,
pHA-GCM1, pHA-GCM1SSAA (which encodes
HA-GCM1 with Ser-to-Ala mutations in Ser269 and
Ser275) and pPKAcata (which encodes the catalytic
subunit of PKA), followed by treatment with or without
forskolin. After coimmunoprecipitation analysis, the
interaction between DUSP23-FLAG and HA-GCM1,
but not HA-GCM1SSAA, was enhanced when the PKA
catalytic subunit was coexpressed or in the presence of
forskolin (Figure 5D). Furthermore, when both Ser269
and Ser275 were changed into glutamic acid, the resultant
HA-GCM1SSEE exhibited higher binding activity with
DUSP23 than the wild-type HA-GCM1 (Figure 5E).
Taken together, these results suggest that activation of
cAMP/PKA-signaling leads to Ser269 and Ser275 phos-
phorylation and enhanced interaction between GCM1 and
DUSP23.
Regulation of trophoblastic fusion by DUSP23
We next tested whether DUSP23 is involved in the regu-
lation of trophoblastic fusion. To this end, BeWo cells
expressing scramble or DUSP23 shRNA were co-cultured
with 293T cells expressing DsRed protein, followed
by treatment with or without forskolin. As shown in
Figure 6A, forskolin stimulated fusion between 293T
cells expressing DsRed and BeWo cells expressing
scramble shRNA (compare panels a and b, 0.26%
versus 5.97% in terms of fusion index). Interestingly, the
fusion activity of BeWo cells induced by forskolin was
barely detected when DUSP23 was knocked down
(compare panels b and d, 5.97% versus 0.49% in terms
of fusion index). These results suggest that DUSP23 is
required for the regulation of trophoblastic fusion by
cAMP/PKA signaling.
We further studied the role of DUSP23 in regulation of
GCM1 target gene expression using BeWo cells expressing
scramble or DUSP23 shRNA, treated with or without
forskolin, followed by quantitative real-time PCR
analysis of the transcripts of GCM1 target genes including
syncytin-1, syncytin-2, PGF and MFSD2 (syncytin-2
receptor). As shown in the left panel of Figure 6B,
DUSP23 knockdown exerted a modest suppressive effect
on the expression of syncytin-1 and syncytin-2 transcripts,
but a stronger suppressive effect on the expression of PGF
and MFSD2 transcripts. As expected, forskolin stimulated
the expression of all four GCM1 target genes, which was
correlated with an increase of GCM1 protein level (154%
relative to mock scramble shRNA-expressing cells,
compare lanes 1 and 3 in the right panel of Figure 6B).
However, the stimulatory effect of forskolin on GCM1
target gene expression was suppressed when DUSP23
was knocked down, which was also correlated with a
decrease in GCM1 protein level (154% versus 66%,
compare lanes 3 and 4 in the right panel of Figure 6B).
Taken together, these results suggest that DUSP23 is
required for activation of the GCM1 transcriptional
network by the cAMP/PKA-signaling pathway that
leads to trophoblastic fusion.
Coordination of GCM1 dephosphorylation and acetylation
in regulation of GCM1 stability
The observation that DUSP23 knockdown suppresses the
positive effect of forskolin on GCM1 stability suggested
that dephosphorylation of Ser322 may be a prerequisite
Nucleic AcidsResearch, 2011, Vol.39,No. 3 855Figure 5. Regulation of GCM1 phosphorylation and GCM1–DUSP23 interaction. (A) Forskolin (FSK) stimulates the interaction between DUSP23
and GCM1. BeWo cells were treated with or without 50mM forskolin for 24h, followed by immunoprecipitation with normal IgG or GCM1
antibody and immunoblotting with DUSP23 and GCM1 antibodies, respectively. Note that speciﬁc interaction between GCM1 and DUSP23 was
detected in immunoprecipitation with GCM1 antibody, but not normal IgG. The levels of Ser269- and Ser275-phosphorylated GCM1 and DUSP23
proteins in mock- or forskolin-treated BeWo cells were analyzed by immunoblotting with p-Ser269275-GCM1 and DUSP23 antibodies, respectively.
Arrow and asterisk indicate the positions of the Ser269- and Ser275-phosphorylated GCM1 and a non-speciﬁc protein, respectively. In a separate
experiment, cells were harvested for quantitative real-time PCR analysis of DUSP23 transcript. Mean values and the SD obtained from three
independent experiments are presented. (B) Phosphorylation of Ser269 and Ser275 by PKA enhances DUSP23-GCM1 interaction. 0.5mgo f
matrix-bound MBP or MBP-GCM1(167–349) was incubated with PKA for in vitro kinase reaction and then with 0.1mg of recombinant
DUSP23-FLAG in pull-down experiments. Phosphorylation of Ser269 and Ser275 in MBP-GCM1(167–349) was analyzed by immunoblotting
with p-Ser269275-GCM1 antibody (middle panel). The lower panel is Coomassie brilliant blue staining of MBP (arrowhead) and
MBP-GCM1(167–349) (arrow) in pull-down assays. (C) Activation of cAMP/PKA signaling stimulates Ser269 and Ser275 phosphorylation and
enhances the interaction between GCM1 and DUSP23 in BeWo and primary cytotrophoblast cells. BeWo or CTB cells were treated with the
indicated combinations of forskolin and H89. After 24h incubation, cells were harvested for immunoblotting with p-Ser269275-GCM1 antibody.
Arrow and asterisk indicate the positions of the Ser269- and Ser275-phosphorylated GCM1 and a non-speciﬁc protein, respectively. In a separate
experiment, the cell lysates were subjected to immunoprecipitation with GCM1 antibody and immunoblotting with DUSP23 antibody. Arrowhead
indicates the position of DUSP23. (D) Mutagenesis of Ser269 and Ser275 abolishes the enhancement effect of PKA and forskolin on DUSP23-GCM1
interaction. 293T cells were transfected with the indicated expression plasmids for 24h, followed by treatment with or without 50mM forskolin for
additional 24h. Cells were harvested for immunoprecipitation and immunoblotting with HA and FLAG mAbs. Note that coexpression of PKA or
treatment with forskolin enhances the interaction between DUSP23 and the wild-type GCM1, but not the GCM1SSAA mutant. (E) Enhanced
interaction between DUSP23 and phospho-mimetic GCM1 mutant, GCM1SSEE. 293T cells were transfected with the indicated expression plasmids
for 24h. Cells were harvested for immunoprecipitation and immunoblotting with HA and FLAG mAbs.
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pathway. We next investigated the potential interplay
between GCM1 dephosphorylation and acetylation. We
hypothesized that GCM1 dephosphorylation may facili-
tate subsequent CBP-mediated GCM1 acetylation to
increase GCM1 stability and activity. Because acetylation
of GCM1 by CBP protects GCM1 from ubiquitination,
we ﬁrst studied the interplay between DUSP23 and CBP
in regulation of GCM1 ubiquitination in 293T cells trans-
fected with different combinations of pGCM1-Myc,
pGCM1K3R-Myc, pHA-Ub, pCBP-FLAG, pDUSP23-
Myc and pDUSP23DACS-Myc expression plasmids. As
shown in Figure 7A, CBP protected GCM1 from
ubiquitination, which could be further enhanced by
DUSP23 (lanes 4 and 5). However, this protection effect
was counteracted by DUSP23DACS (compare lanes 4 and
Figure 6. DUSP23 is required for cAMP/PKA-induced placental cell fusion. (A) DUSP23 knockdown suppresses placental cell fusion regulated by
forskolin. 293T cells expressing the DsRed protein were co-cultured with BeWo cells expressing scramble or DUSP23-speciﬁc shRNA and treated
with or without 50mM forskolin for 24 h. Cell fusions were examined under a ﬂuorescence microscope and analyzed by fusion index analysis. Arrows
indicate syncytia in the forskolin-treated cells. Bar, 100mm. Mean values and the SD obtained from three independent experiments are presented. (B)
DUSP23 knockdown suppresses GCM1 target gene expression. BeWo cells expressing scramble or DUSP23 shRNA were treated with or without
50mM forskolin for 24h. Cells were then harvested for RNA puriﬁcation and quantitative real-time PCR analysis with primer sets speciﬁc for the
indicated GCM1 target genes (left). Syn1, syncytin-1; Syn2, syncytin-2. Mean values and the SD obtained from three independent experiments are
presented. The Student’s t-test was used to determine statistical signiﬁcance for differences between means for scramble and DUSP23
shRNA-expressing cells. A P-value of<0.05 was considered signiﬁcant (**=P<0.01, *=P<0.05). In a separate experiment, cells were harvested
for immunoblotting analysis of GCM1, DUSP23 and b-actin with the indicated antibodies (right). The numbers underneath indicate the ratios of the
GCM1 or DUSP23 band intensity (normalized against b-actin) relative to that in mock scramble shRNA-expressing cells.
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(17), GCM1K3R, which harbors Lys-to-Arg mutations
in the three major acetylation sites in GCM1, Lys367,
Lys406 and Lys409, was ubiquitinated even in the
presence of CBP. Although CBP failed to protect
GCM1K3R from ubiquitination (lane 9, Figure 7A),
GCM1K3R ubiquitination was dramatically decreased
in the presence of wild-type DUSP23, but not
DUSP23DACS (compare lanes 10 and 11 in Figure 7A).
These results suggest that dephosphorylation of GCM1 by
DUSP23 may enhance GCM1 acetylation by CBP and
thereby protect GCM1 from ubiquitination.
We further studied whether GCM1 dephosphorylation
by DUSP23 is a prerequisite step to CBP-mediated GCM1
acetylation. To this end, 293T cells expressing scramble or
DUSP23 shRNA were transfected with pGCM1-Myc and
pCBP-FLAG, followed by treatment with or without the
proteasome inhibitor, MG132. As shown in Figure 7B,
acetylation of GCM1 by CBP was signiﬁcantly decreased
in 293T cells expressing DUSP23 shRNA compared with
that in 293T cells expressing scramble shRNA (compare
lanes 2 and 6). Nevertheless, the negative effect of
DUSP23 knockdown on CBP-mediated GCM1 acetyl-
ation was neutralized in the presence of MG132 as a
similar level of acetylated GCM1 was detected in both
cell types (compare lanes 4 and 8 in Figure 7B). We also
tested the effect of DUSP23 on GCM1 acetylation in
BeWo31 cells expressing scramble or DUSP23 shRNA
after treatment with or without forskolin and the
HDAC inhibitor, TSA. As shown in Figure 7C, GCM1
acetylation was evident in the presence of forskolin and
TSA in BeWo31 cells expressing scramble shRNA, but
barely detected in BeWo31 cells expressing DUSP23
shRNA (compare lanes 2 and 8). Again, the levels
of acetylated GCM1 were comparable in both cell types
when the cells were treated with MG132 (compare lanes 4
and 10 in Figure 7C). This was most likely due to MG132
inhibition of degradation of Ser322-phosphorylated
GCM1 proteins and subsequent acetylation of the
proteins by CBP. Indeed, this speculation was supported
Figure 7. Coordination of GCM1 dephosphorylation and acetylation. (A) Interplay between DUSP23 and CBP in regulation of GCM1
ubiquitination. 293T cells were transfected with different combinations of 2mg of pGCM1-Myc, 0.5mg of pHA-Ub, 1mg of pCBP-FLAG, 2mgo f
pDUSP23-Myc and 2mg of pDUSP23DACS-Myc. At 48h post-transfection, cells were treated with 40mM MG132 for an additional 6h and then
subjected to immunoprecipitation and immunoblotting with GCM1 antibody, and HA, FLAG and Myc mAbs. (B) DUSP23-mediated GCM1
dephosphorylation facilitates CBP-mediated GCM1 acetylation. 293T cells expressing scramble or DUSP23 shRNA were transfected with 2mgo f
pGCM1-Myc and 1mg of pCBP-FLAG. At 48h post-transfection, cells were treated with 40mM MG132 for an additional 10h and then subjected to
immunoprecipitation and immunoblotting with GCM1 antibody, and Ac-K and Myc mAbs. Arrow indicates the position of acetylated GCM1. (C)
Dephosphorylation of GCM1 by DUSP23 facilitates GCM1 acetylation in placental cells. BeWo31 cells expressing scramble or DUSP23 shRNA
were mock-treated or treated with 10mM forskolin and 50ng/ml TSA for 24h for immunoprecipitation and immunoblotting with Ac-K and HA
mAbs. In a separate experiment, cells were further treated with 20mM MG132 for additional 10h before harvesting for the above-described analysis.
The numbers underneath lanes 6 and 12 indicate the ratios of the acetylated and Ser322-phosphorylated HA-GCM1 band intensity (normalized
against Ser322-phosphorylated HA-GCM1) in FSK- and TSA-treated cells to that in mock-treated cells.
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Ser322-phosphorylated GCM1 protein level was compar-
able in both control and DUSP23-knockdown BeWo31
cells in the presence of MG132 (157% versus 156%,
compare lanes 6 and 12 in Figure 7C). Taken together,
these results suggest that GCM1 dephosphorylation by
DUSP23 facilitates subsequent GCM1 acetylation by
CBP.
DISCUSSION
Here we conﬁrmed that DUSP23 is a functional phosphat-
ase involved in GCM1 dephosphorylation and regulation
of GCM1 activity in placenta. Several lines of evidence
support this conclusion. First, GCM1 physically interacts
with DUSP23. Domain mapping analysis further
identiﬁed that the region of amino acids 167–349 in
GCM1 is required for interaction with DUSP23. Second,
DUSP23 is able to dephosphorylate Ser322 in GCM1
in vitro and in a stable cell line expressing HA-GCM1.
Third, DUSP23 prevents GCM1 from ubiquitination
and prolongs its half-life. As Ser322 phosphorylation is
required for GCM1 ubiquitination and degradation,
dephosphorylation of Ser322 by DUSP23 protects
GCM1 from ubiquitination. Fourth, DUSP23
knockdown not only reduces GCM1 protein level, but
also suppresses GCM1 target gene expression in placental
cells. Correspondingly, the fusion activity of placental
BeWo cells stimulated by PKA is signiﬁcantly suppressed
when DUSP23 is knocked down.
Protein phosphorylation mediated by kinases modu-
lates metabolism, signal transduction, protein–protein
interaction and protein degradation. In order to
maintain cellular homeostasis, phosphorylated proteins
are subjected to dephosphorylation by phosphatases.
DUSPs, a family member of the type-I cysteine-based
PTP superfamily, feature the ability to dephosphorylate
tyrosine, serine and threonine residues. This
dephosphorylation ability depends on the signature
motif, HCXXXXXR, in the catalytic domains of DUSPs
(19). Mitogen-activated protein kinase phosphatases
(MKPs) are DUSPs with substrate speciﬁcity preference
for one or more of the MAPKs: ERK, JNK and p38.
Therefore, MKPs are critical regulators of MAPK signal-
ing when MAPKs are phosphorylated and activated in
response to extracellular stimuli (23). DUSP23 is a low
molecular weight DUSP without an extended N-terminal
domain found in MKPs. DUSP23 and other low molecu-
lar weight DUSPs, DUSP3 and DUSP22, are similar to
the vaccinia virus VH1 phosphatase in terms of domain
structure (19,24,25). Interestingly, VH1, DUSP3 and
DUSP22 are involved in regulation of interferon and
interleukin-signaling pathways by binding and
dephosphorylating STAT proteins (26–28). It is not
known whether DUSP23 has similar effects on STAT
proteins.
Previous studies have provided conﬂicting results
indicating that DUSP23 may dephosphorylate ERK or
activate JNK and p38 in different cell types (25,29).
Nevertheless, in the present study we not only identiﬁed
GCM1 as a bona ﬁde biological substrate for DUSP23,
but also revealed a novel biological function for
DUSP23 in regulation of placental cell fusion by
controlling GCM1 dephosphorylation and stability. We
mapped the interaction domain of GCM1 for DUSP23
to the region of amino acids 167–349, which also
harbors the Ser322 residue critical for GCM1 stability.
However, the interaction between GCM1 and DUSP23
seems to be independent of Ser322 phosphorylation and
the phosphatase activity of DUSP23 as both recombinant
DUSP23 and DUSP23DACS bind efﬁciently to
non-phosphorylated MBP-GCM1(167–349)
(Supplementary Figure S3A). In addition, our in vitro
studies indicated that DUSP23 dephosphorylates Ser322,
but not Ser269 and Ser275 (Supplementary Figure S3B),
suggesting that dephosphorylation of Ser269 and Ser275 is
mediated by other phosphatase. As Ser269 and Ser275 are
within the DUSP23-interacting domain in GCM1 (amino
acids 167–349), it will be instructive to investigate how
phosphorylation of Ser269 and Ser275 in GCM1 facili-
tates its interaction with DUSP23.
That DUSP23-mediated Ser322 dephosphorylation
plays an important role in regulation of GCM1 stability
is supported by the ﬁnding that DUSP23 and
DUSP23DACS are able to decrease and increase GCM1
ubiquitination, respectively (Figure 3A). Accordingly, the
half-life of GCM1 is increased and decreased by DUSP23
and DUSP23DACS, respectively (Figure 3B). In addition,
our recent study indicates that the mutant GCM1S322A,
which harbors a Ser322-to-Ala mutation, is resistant to
ubiquitination and very stable (15). Because Ser322 phos-
phorylation is required for FBW2 recognition and Ser322
is no longer available in GCM1S322A, its stabilization is
very likely due to prevention of FBW2-mediated
ubiquitination, instead of Ser322 dephosphorylation by
DUSP23. Collectively, these ﬁndings also support that
the intracellular fate of Ser322-phosphorylated GCM1 is
under control of FBW2 and DUSP23.
Recent studies have demonstrated that the interplay
between different types of post-translational modiﬁcation
is important in the regulation of protein activity and signal
transduction. A phosphorylation–acetylation switch is
involved in regulation of STAT1 signaling, such that
STAT1 acetylation by CBP facilitates its
dephosphorylation by TCP45 phosphatase and thereby
suppresses the STAT1 signaling (30). On the other hand,
CDC6, which is a regulator of DNA replication, is
acetylated by GCN5 and is then susceptible to phosphor-
ylation by cyclin A-CDKs in early S phase. These sequen-
tial modiﬁcations facilitate translocation of CDC6 to the
cytoplasm for proper S-phase progression (31). By
analogy, an interplay between different types of post-
translational modiﬁcation of GCM1 may provide precise
ﬁne-tuning of GCM1 activity in regulation of placental
development and function. Indeed, the present study has
demonstrated that Ser322 dephosphorylation in GCM1 by
DUSP23 facilitates GCM1 acetylation by CBP in the
cAMP/PKA-signaling pathway.
The coordination of GCM1 dephosphorylation and
acetylation is of physiological signiﬁcance. Because
syncytiotrophoblast layer undergoes apoptosis and sheds
Nucleic AcidsResearch, 2011, Vol.39,No. 3 859into the circulation, replenishment of new
syncytiotrophoblast layer is expected to be tightly
controlled through regulation of GCM1 stability and
activity. In this scenario, phosphorylation of Ser322 in
GCM1 by GSK-3b and dephosphorylation of Ser322 by
DUSP23 may respectively serve as a negative and a
positive regulator maintaining proper GCM1 activity in
placenta. When exposed to pathological hypoxia, over-
activated GSK-3b promotes Ser322 phosphorylation;
consequently, GCM1 is ubiquitinated and degraded
leading to breakdown of the GCM1 transcriptional
network in preeclampsia (15). Nevertheless, Ser322-
phosphorylated GCM1 is rescued from degradation
by DUSP23 in order to promote trophoblastic fusion
when new syncytiotrophoblast layer is needed to meet
the physiological demands. In this regard, activation
of cAMP/PKA-signaling leads to phosphorylation of
Ser269 and Ser275 in GCM1, which enhances the recruit-
ment of DUSP23 to mediate Ser322 dephosphorylation
and increase the protein level of GCM1. Finally, CBP
mediates GCM1 acetylation to further stabilize GCM1
and the CBP-GCM1 complex synergistically trans-
activates syncytin and syncytin receptor expression
to facilitate trophoblastic fusion. Collectively, our
study revealed a novel physiological function for
DUSP23 in control of trophoblastic fusion via GCM1
dephosphorylation. Our study also revealed that
coordinated GCM1 phosphorylation, dephosphorylation
and acetylation are involved in cAMP/PKA-induced
GCM1 activation and trophoblastic fusion.
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